Skip to main content
Clinical Trials/NCT06900790
NCT06900790Not yet recruitingNot Applicable

A Single-Center Retrospective Cohort Study Evaluating the Management and Outcomes of Pediatric Pancreatic Duct Stones Using Endoscopic and Surgical Techniques

Yifan Deng0 sites60 target enrollmentStarted: April 23, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60
Primary Endpoint
stone clearance

Study Overview

Brief Summary

The goal of this observational study is to evaluate the long-term effects of ERCP and surgery in pediatric patients with pancreatic duct stones. The main objective is to determine the optimal treatment choice(ERCP or surgery) for children with pancreatic duct stones and identify the appropriate timing for surgery in patients who have undergone multiple ERCP procedures, in order to avoid adverse outcomes caused by repeated trauma to the duodenal papilla.

Last updated on January 24, 2025.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
2 Months to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients aged 0 to 18 years
  • •Diagnosed with pancreatic duct stones by imaging (e.g., ultrasound, CT, MRCP)
  • •Treated and followed at pediatric surgery, west china hospital, between 2014 and 2025
  • •Complete clinical data available for review

Exclusion Criteria

  • •Pancreatic duct stones secondary to previous pancreatic or biliary surgery
  • •Concurrent severe systemic diseases (e.g., advanced cardiac, renal, or hepatic disease)
  • •Incomplete or missing key clinical records

Outcomes

Primary Outcomes

stone clearance

Time Frame: From intervention to the end of treatment at 1 week

The stone clearance rate refers to the proportion of patients confirmed by postoperative imaging (MRCP) to have no residual pancreatic duct stones.

complication rate

Time Frame: From enrollment to the end of treatment at 2 weeks

The complication rate refers to the incidence of pancreatitis following ERCP and associated procedures, as well as pancreatic fistula, bile leakage, and the necessity for prolonged drainage after the Frey procedure.

reintervention rate

Time Frame: From enrollment to the end of treatment at 1 year.

The reintervention rate refers to the proportion of patients who required additional invasive procedures (either ERCP or surgery) after the initial treatment.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Yifan Deng
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Yifan Deng

M.Med

West China Second University Hospital

Similar Trials